Blog
Snap Q2 Earnings Call Highlights
Key Points
- Interested in Snap Inc.? Here are five stocks we like better.
- Snap’s second-quarter revenue rose 19% to $1.6 billion, supported by a 9% increase in advertising revenue and an 85%
Medifast Q2 Earnings Call Highlights
Key Points
- Interested in Medifast Inc? Here are five stocks we like better.
- Q2 performance weakened: Revenue fell 27.6% year over year to $76.4 million, and Medifast posted a $3.1 million net
Matson Q2 Earnings Call Highlights
Key Points
- Interested in Matson, Inc.? Here are five stocks we like better.
- Matson reported strong second-quarter results, with operating income up $45.9 million year over year to $158.9
Inspire Medical Systems Q2 Earnings Call Highlights
Key Points
- Interested in Inspire Medical Systems, Inc.? Here are five stocks we like better.
- Second-quarter revenue fell 7.6% to $200.6 million as coding and reimbursement disruptions reduced
Ibotta Q2 Earnings Call Highlights
Key Points
- Interested in Ibotta, Inc.? Here are five stocks we like better.
- Ibotta returned to year-over-year growth earlier than expected: Q2 revenue rose 3% to $88.9 million, redemption
Clorox Q4 Earnings Call Highlights
Key Points
- Interested in The Clorox Company? Here are five stocks we like better.
- Fiscal 2027 outlook: Clorox expects organic sales to be flat to slightly higher amid muted category growth and
GeneDx Q2 Earnings Call Highlights
Key Points
- Interested in GeneDx Holdings Corp.? Here are five stocks we like better.
- GeneDx exceeded expectations in Q2, reporting $114.4 million in revenue and a record 30,785 exome and genome
Allison Transmission Q2 Earnings Call Highlights
Key Points
- Interested in Allison Transmission Holdings, Inc.? Here are five stocks we like better.
- Allison Transmission reported strong second-quarter results, with sales up 92% year over year
Ameresco Q2 Earnings Call Highlights
Key Points
- Interested in Ameresco, Inc.? Here are five stocks we like better.
- Ameresco reported strong Q2 growth, with revenue up 9% year over year to $515 million, adjusted EBITDA up 12% to
BWX Technologies Q2 Earnings Call Highlights
Key Points
- Interested in BWX Technologies, Inc.? Here are five stocks we like better.
- BWXT reported strong Q2 results, with revenue up 18% to $902 million, adjusted EPS up 5% to $1.70, and
Vertex Q2 Earnings Call Highlights
Key Points
- Interested in Vertex, Inc.? Here are five stocks we like better.
- Strong Q2 profitability: Revenue increased 10.5% year over year to $204 million, while adjusted EBITDA rose 33% to $51
Ultra Clean Q2 Earnings Call Highlights
Key Points
- Interested in Ultra Clean Holdings, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose to $644.9 million from $533.7 million in Q1, while net income
Vertex Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better.
- Vertex reported strong Q2 growth: Revenue rose 12% year over year to $3.3 billion, prompting
Backblaze Q2 Earnings Call Highlights
Key Points
- Interested in Backblaze, Inc.? Here are five stocks we like better.
- Backblaze exceeded Q2 expectations: Revenue rose 18% year over year to $42.7 million, while adjusted EBITDA nearly
onsemi Q2 Earnings Call Highlights
Key Points
- Interested in onsemi? Here are five stocks we like better.
- Strong second-quarter performance: onsemi reported $1.6 billion in revenue, up 6% sequentially and 9% year over year, with
SBA Communications Q2 Earnings Call Highlights
Key Points
- Interested in SBA Communications Corporation? Here are five stocks we like better.
- SBA Communications modestly raised its 2026 outlook for site leasing revenue, funds from
Stoke Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Stoke Therapeutics, Inc.? Here are five stocks we like better.
- EMPEROR remains on schedule: Stoke completed enrollment ahead of plan with 162 Dravet syndrome patients
Ethos Technologies Inc. Class A Common Stock Q2 Earnings Call Highlights
Key Points
- Interested in Ethos Technologies Inc. Class A Common Stock? Here are five stocks we like better.
- Strong growth continued: Second-quarter revenue rose 113% year over year to $189.6
SiBone Q2 Earnings Call Highlights
Key Points
- Interested in SiBone? Here are five stocks we like better.
- Strong second-quarter performance: SiBone’s revenue rose 15.2% year over year to $56 million, driven by nearly 15% U.S
Palantir Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Palantir Technologies Inc.? Here are five stocks we like better.
- Palantir’s Q2 revenue surged 93% year over year to $1.935 billion, led by U.S. revenue growth of 115%
Jazz Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Jazz Pharmaceuticals PLC? Here are five stocks we like better.
- Jazz Pharmaceuticals reported record second-quarter revenue of $1.21 billion, up 16% year over year, and
Ichor Q2 Earnings Call Highlights
Key Points
- Interested in Ichor Holdings, Ltd.? Here are five stocks we like better.
- Demand and outlook strengthened: Second-quarter revenue rose 15% sequentially to $294.8 million, while Ichor
EverQuote Q2 Earnings Call Highlights
Key Points
- Interested in EverQuote, Inc.? Here are five stocks we like better.
- Strong Q2 performance: EverQuote’s revenue rose 25% year over year to $195.1 million, while adjusted EBITDA
ClearPoint Neuro Q2 Earnings Call Highlights
Key Points
- Interested in ClearPoint Neuro, Inc.? Here are five stocks we like better.
- Q2 revenue increased 18% to $10.9 million, driven by neurosurgery navigation, therapy products and capital
Adeia Q2 Earnings Call Highlights
Key Points
- Interested in Adeia Inc.? Here are five stocks we like better.
- Adeia reported solid Q2 results, with revenue of $96.1 million, adjusted EBITDA of $56.4 million and a 59% margin. The